Sorry but I am not a believer in charts for penny stocks but I am a believer in companies that have a good management team with solid backgrounds and with products that are disruptive. I have not seen one thing that concerns me as the development continues. My business experience has taught me that things do not always develop as fast as I would want but steady progression is the key. This definitely applies to the bio world. Very happy here and waiting for a significant license agreement and/or partnership to develop along with Immune product sales. All good with not concern!
Market Data 
Markets 
AI
